These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10878501)

  • 1. Adrenocorticotropin inhibition by restoration of normal evening cortisol levels: a measure of putative hippocampus-mediated glucocorticoid feedback in humans.
    Goldman MB; Wood GJ
    Neuroendocrinology; 2000 Jun; 71(6):396-401. PubMed ID: 10878501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging.
    Wilkinson CW; Peskind ER; Raskind MA
    Neuroendocrinology; 1997 Jan; 65(1):79-90. PubMed ID: 9032777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin secretory dynamics in humans under low glucocorticoid feedback.
    Veldhuis JD; Iranmanesh A; Naftolowitz D; Tatham N; Cassidy F; Carroll BJ
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5554-63. PubMed ID: 11701735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human glucocorticoid feedback inhibition is reduced in older individuals: evening study.
    Wilkinson CW; Petrie EC; Murray SR; Colasurdo EA; Raskind MA; Peskind ER
    J Clin Endocrinol Metab; 2001 Feb; 86(2):545-50. PubMed ID: 11158007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to glucocorticoid feedback in obesity.
    Jessop DS; Dallman MF; Fleming D; Lightman SL
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4109-14. PubMed ID: 11549634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a delayed, integral, and proportional phase of glucocorticoid feedback on ACTH secretion in normal human volunteers.
    Won JG; Jap TS; Chang SC; Ching KN; Chiang BN
    Metabolism; 1986 Mar; 35(3):254-9. PubMed ID: 3005801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
    Goldman MB; Wood G; Goldman MB; Gavin M; Paul S; Zaheer S; Fayyaz G; Pilla RS
    J Clin Endocrinol Metab; 2007 Feb; 92(2):698-704. PubMed ID: 17118992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
    Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E
    Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: relationships to magnetic resonance imaging-derived hippocampus and cingulate gyrus volumes.
    Wolf OT; Convit A; de Leon MJ; Caraos C; Qadri SF
    Neuroendocrinology; 2002 Apr; 75(4):241-9. PubMed ID: 11979054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol feedback effects on plasma corticotropin levels in healthy subjects.
    Posener JA; Schildkraut JJ; Williams GH; Schatzberg AF
    Psychoneuroendocrinology; 1997 Apr; 22(3):169-76. PubMed ID: 9203227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ; Young EA; Andrew R; Seckl JR
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):22-6. PubMed ID: 16817814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man.
    Boscaro M; Paoletta A; Scarpa E; Barzon L; Fusaro P; Fallo F; Sonino N
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1380-3. PubMed ID: 9543170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.